Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3195 EUR | +5.27% | +3.06% | -18.08% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.08% | 13.51M | |
+25.06% | 46.71B | |
+48.83% | 41.8B | |
-0.93% | 41.52B | |
-3.42% | 29.55B | |
+10.22% | 25.78B | |
-20.56% | 19.26B | |
+0.67% | 12.14B | |
-0.18% | 12.08B | |
+26.17% | 11.98B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Transcript : Celyad Oncology SA, H1 2022 Earnings Call, Aug 05, 2022